BHIVA challenges BMJ recommendations on ART during pregnancy: tenofovir still strongly recommend
1 December 2017. Related: PMTCT and maternal health.
Simon Collins, HIV i-Base
On 21 September, the British HIV Association (BHIVA) took the unusual step of issuing a statement (reproduced below) to publicly challenge a recent paper from the British Medical Journal (BMJ). The statement also challenged the linked BMJ recommendations, especially over choice of ART during pregnancy.